money.rediff1d
Natco Pharma Gets US FDA Approval for Generic Everolimus Tablets
Natco Pharma has received US FDA approval for its generic version of Everolimus tablets for oral suspension, indicated for ...
U.S. FDA nod for Natco Pharma’s generic of Novartis drug
Natco Pharma receives FDA approval for Everolimus tablets, launching generic version of Afinitor Disperz in U.S. market.
Natco Pharma gets nod for generic Everolimus tablets
The approval is for the Abbreviated New Drug Application (ANDA) for Everolimus tablets for oral suspension (TFOS) of ...
Daily1d
Natco Pharma gets approval for Everolimus tablets for Oral Suspension for subependymal giant cell astrocytoma
Hyderabad: NATCO Pharma Limited, an Indian pharmaceutical company, has announced the approval of its Abbreviated New Drug ...
NATCO Pharma gets approval for its ANDA for Everolimus tablets
NATCO Pharma said that it has received approval of its ANDA for Everolimus tablets for oral suspension (TFOS), a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation.
Breckenridge Announces Final FDA Approval For Everolimus Tablets For Oral Suspension, AB-Rated To AFINITOR DISPERZ®
Everolimus TFOS is a kinase inhibitor indicated in adult and pediatric patients aged one year and older with tuberous sclerosis complex ("TSC") for the treatment of subependymal giant cell astrocytoma ...
Natco Pharma receives approval for its ANDA for Everolimus tablets for oral suspension
Natco Pharma announced approval of its ANDA for Everolimus tablets for oral suspension (TFOS), 2mg, 3mg and 5mg, a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation. NATCO's ...